• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGU313110
Device Problems Material Separation (1562); Activation Failure (3270)
Patient Problem Ischemia (1942)
Event Date 05/11/2022
Event Type  Injury  
Event Description
The following was reported to gore: on (b)(6) 2022, the patient underwent endovascular treatment for acute type a dissection using a 31mm x 31mm x 10cm conformable gore® tag® thoracic endoprosthesis (ctag).The ctag was advanced through 0.035 boston super stiff wire to descending aorta.The physician didn't feel resistance when pulling deployment line during deployment.After he thought that the deployment line was fully pulled out, he tried to remove the delivery catheter.However, the delivery catheter couldn't be removed.Then it was found that the ctag was partially expanded by x-ray examination.The deployment line was broken when distal end of stent was deployed and proximal part was constrained.The physician used kelly device to shrink the partial expanded ctag to pull it out.Another ctag was used to complete procedure.The procedure was prolonged for about 30mins to remove the ctag.The patient tolerated the procedure and had minor ischemia bowel syndrome within three days after procedure.He has recovered now.
 
Manufacturer Narrative
A review of the manufacturing records indicated the lot met all pre-released specifications.
 
Event Description
The following was reported to gore: on (b)(6), 2022, the patient underwent endovascular treatment for acute type a dissection using a 31mm x 31mm x 10cm conformable gore® tag® thoracic endoprosthesis (ctag).The patient was open chest.The physicians used frozen elephant trunk technique and planned to implant ctag retrograde.The ctag was advanced through 0.035 boston super stiff wire to descending aorta.The physician didn't feel resistance when pulling deployment line during deployment.After he thought that the deployment line was fully pulled out, he tried to remove the delivery catheter.However, the delivery catheter couldn't be removed.Then it was found that the ctag was partially expanded by x-ray examination.The deployment line was broken when distal end of stent was deployed and proximal part was constrained.The physician used kelly device to shrink the partial expanded ctag to pull it out.Another ctag was used to complete procedure.The procedure was prolonged for about 30mins to remove the ctag.The patient had minor ischemia bowel syndrome causing by trouble shooting of ctag within three days after procedure.He tolerated the procedure and has recovered now.
 
Manufacturer Narrative
Update b1, b2, b5, g3.Imaging evaluation: one jpeg image received for evaluation.No name, date, or demographics on the radiographic image.Image provided appears to show a partially deployed and partially constrained device.Engineering evaluation: the proximal end of the device was still constrained, and the deployment line associated with the leading end was broken as described in the event description.The slip knots that constrain the proximal end of the device had not released and showed no signs of tensile strain, damage, or incorrect fiber routing.The core and outer wrap of the fiber appeared to have experienced tensile forces and are not indicative of a clean cut.A split to the inner core is present which may have resulted in a weakened fiber, but this relationship and the cause of the split could not be confirmed.The reason for deployment not completing on the proximal end of the device is likely due to break of the leading end deployment line before the slip knots could release.The cause of the deployment line breaking could not be confirmed with the currently available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14570840
MDR Text Key293365536
Report Number2017233-2022-02978
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132618033
UDI-Public00733132618033
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTGU313110
Device Catalogue NumberTGU313110
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2022
Initial Date FDA Received06/01/2022
Supplement Dates Manufacturer Received09/16/2022
Supplement Dates FDA Received09/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age41 YR
Patient SexMale
-
-